Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
02/20/2013 | CN102939107A Antibody preparations |
02/20/2013 | CN102939106A Protein formulations |
02/20/2013 | CN102939105A Immunogenic compositions and related methods |
02/20/2013 | CN102939104A Concentration of vaccine antigens with lyophilization |
02/20/2013 | CN102939103A Influenza virus vaccines and uses thereof |
02/20/2013 | CN102939102A Recombinant multimeric influenza proteins |
02/20/2013 | CN102939101A Influenza virus compositions and methods for universal vaccines |
02/20/2013 | CN102939100A Enzymatic composition for the digestion of chicken embryos |
02/20/2013 | CN102939099A Treating allergy with detoxified e. coli heat-labile enterotoxin |
02/20/2013 | CN102939098A Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
02/20/2013 | CN102936287A Antibody capable of binding specifically to A beta-oligomer, and use thereof |
02/20/2013 | CN102936286A Anti-anthrax PA antigen monoclonal antibody and applications thereof |
02/20/2013 | CN102936285A Antibody for preventing and treating fish Edwardsiellaictaluri disease, preparation method and applications thereof |
02/20/2013 | CN102936284A 人抗狂犬病抗体及其用途 Human anti-rabies antibodies and their use |
02/20/2013 | CN102936283A Anti-human CD146 monoclonal antibodies, compositions containing anti-human CD146 monoclonal antibodies, and soluble CD146 detection method |
02/20/2013 | CN102936278A Epitope polypeptide of dengue virus type 2 NS3 protein and application thereof |
02/20/2013 | CN102936277A Human blood vessel endothelial growth factor antigen epitope and epitope vaccine thereof |
02/20/2013 | CN102935240A Rabbit hemorrhagic disease virus (RHDV) 'suicide' deoxyribonucleic acid (DNA) vaccine and construction method thereof |
02/20/2013 | CN102935228A Reagent for tumor treatment, its use and method |
02/20/2013 | CN102935227A Newcastle disease virus hemagglutinin-neuraminidase (HN) gene subunit vaccine and preparation method thereof |
02/20/2013 | CN102935226A Typhoid fever and paratyphoid fever combined vaccine and preparation method thereof |
02/20/2013 | CN102344892B Chinese isolate of Leachiii mycoplasma, isolation culture medium and purpose thereof |
02/20/2013 | CN102309759B Poultry freeze-drying live vaccine heat-resisting protective agent and preparation method thereof |
02/20/2013 | CN102233137B Recombinant plasmid DNA vaccine composition for treating Hepatitis B |
02/20/2013 | CN101573384B Antibodies and immunoconjugates and uses therefor |
02/20/2013 | CN101478984B Compositions and methods for treating parasitic infections |
02/19/2013 | USRE44024 Isolation and characterization of ECA1, a gene overexpressed in endometroid carcinomas of ovary and endometrium |
02/19/2013 | US8378087 Recombinant Plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
02/19/2013 | US8378081 Antibodies that specifically bind to Aβ oligomers and uses thereof |
02/19/2013 | US8377959 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
02/19/2013 | US8377945 Small molecule inhibitors of spleen tyrosine kinase (SYK) |
02/19/2013 | US8377690 Cells and methods for producing blocking antibodies to human RANKL |
02/19/2013 | US8377645 Unc-33 like phosphoprotein (ULIP) polypeptide for generating antibodies for use in diagnosis, preventnion and treatment of neurodegenerative and neoplastic disorders |
02/19/2013 | US8377477 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof |
02/19/2013 | US8377452 Use of a botulinum neurotoxin to alleviate various disorders |
02/19/2013 | US8377451 Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
02/19/2013 | US8377450 Clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer |
02/19/2013 | US8377448 CD47 related compositions and methods for treating immunological diseases and disorders |
02/19/2013 | US8377447 Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells |
02/19/2013 | US8377446 Serum resistance factors of gram positive bacteria |
02/19/2013 | US8377445 Compositions of human lipids and methods of making and using same |
02/19/2013 | US8377444 Therapeutic agent or preventive agent for osteoarthritis |
02/19/2013 | US8377443 Antibodies to matrix metalloproteinase 9 |
02/19/2013 | US8377442 Method of treating inflammatory eye disease with IL-1β binding antibodies |
02/19/2013 | US8377441 Treating breast cancer with anti-IL-19 antibody |
02/19/2013 | US8377440 Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases |
02/19/2013 | US8377439 Antagonist antibodies against EPHB3 |
02/19/2013 | US8377438 Methods of antagonizing signal transduction in spinal cord cells |
02/19/2013 | US8377437 C3b antibodies and methods for the prevention and treatment of complement-associated disorders |
02/19/2013 | US8377436 Granulysin and uses thereof |
02/19/2013 | US8377435 Antibody induced cell membrane wounding |
02/19/2013 | US8377429 Methods for improvement of beta cell function with anti-IL-1β antibodies or fragments thereof |
02/19/2013 | US8377420 Injectable void filler for soft tissue augmentation |
02/19/2013 | CA2497279C Mutant forms of meningococcal adp-ribosylating toxin |
02/19/2013 | CA2487137C Tumour-associated peptides that bind to mhc molecules |
02/19/2013 | CA2485120C Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
02/19/2013 | CA2469092C Copolymer 1 vaccine and methods for treatment of amyotrophic lateral sclerosis (als) |
02/19/2013 | CA2467930C Treatment of pml targeting jc virus agno |
02/19/2013 | CA2443088C Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer |
02/19/2013 | CA2442964C Improved anti-inflammatory herbal composition and method of use |
02/19/2013 | CA2375320C Dna vaccines for pets or for animals used in sports |
02/19/2013 | CA2276450C A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
02/19/2013 | CA2233570C Detection, prevention and treatment of papillomatous digital dermatitis |
02/14/2013 | WO2013023162A2 Anti-muc1 antibodies for cancer diagnostics |
02/14/2013 | WO2013023059A2 Methods and compositions for the treatment of autoimmune and inflammatory diseases |
02/14/2013 | WO2013023043A2 Treatment of advanced solid tumors using combination of anti-erbb3 immunotherapy and selected chemotherapy |
02/14/2013 | WO2013022991A2 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer |
02/14/2013 | WO2013022972A1 Methods of treating progressive forms of multiple sclerosis |
02/14/2013 | WO2013022968A1 Antibodies binding to phosphorylcholine (pc) and/or pc conjugates |
02/14/2013 | WO2013022848A1 Anti-polyubiquitin antibodies and methods of use |
02/14/2013 | WO2013022808A2 Immunogenic protein conjugates and methods for making and using the same |
02/14/2013 | WO2013022599A1 Improved methods and compositions for modulation of olfml3 mediated angiogenesis |
02/14/2013 | WO2013022406A1 Angiopoietin-like 4 and its use in modulating cell leakiness |
02/14/2013 | WO2013022091A1 Therapeutic agent for autoimmune diseases comprising pd-1 agonist |
02/14/2013 | WO2013021279A2 Highly galactosylated antibodies |
02/14/2013 | WO2013020995A1 New antibodies against phosphorylcholine |
02/14/2013 | WO2013020988A1 Pasteurellaceae vaccines |
02/14/2013 | WO2013020724A1 Composition comprising a tlr agonist and an antibody specific for an antigen and uses thereof as vaccine |
02/14/2013 | WO2013020723A1 Compositions and uses thereof for the treatment or prevention of alzheimer's disease |
02/14/2013 | WO2013020722A2 Compositions and uses |
02/14/2013 | WO2013020372A1 Methods and reagents for preventing and curing insulin resistance and diabetes mellitus |
02/14/2013 | WO2013020235A1 Methods and compositions for modulating voltage-gated calcium channel function |
02/14/2013 | WO2013020183A1 Immunogenic compositions and methods therefor |
02/14/2013 | WO2012143382A9 Gpr177 as target and marker in tumors |
02/14/2013 | US20130041307 Application of beta-functionalized dihydroxy-chlorins for pdt |
02/14/2013 | US20130041137 von Willebrand Factor (vWF) - Cleaving Protease |
02/14/2013 | US20130040879 Methods For Treating Congestive Heart Failure |
02/14/2013 | US20130039986 Silk-Based Ionomeric Compositions |
02/14/2013 | US20130039974 Anti-muc1 antibodies for cancer diagnostics |
02/14/2013 | US20130039973 Viral Immunogenic Compositions |
02/14/2013 | US20130039971 Compositions and methods for inhibition of vegf |
02/14/2013 | US20130039958 Method of vaccination |
02/14/2013 | US20130039954 Control of antibody responses to synthetic nanocarriers |
02/14/2013 | US20130039947 Novel immunogens and methods for discovery and screening thereof |
02/14/2013 | US20130039946 Vaccine comprising an attenuated pestivirus |
02/14/2013 | US20130039945 Anti-Viral Compounds |
02/14/2013 | US20130039944 Anti-Viral Compounds |
02/14/2013 | US20130039943 Novel method |
02/14/2013 | US20130039942 Compositions and Methods for Self-Adjuvanting Vaccines against Microbes and Tumors |
02/14/2013 | US20130039941 Vaccine comprising inactivated cells of haemophilus parasuis bacteria of serotype 5 |